The Heart of Fetal Growth Restriction: Congenital Heart Defects-An Analysis of Risk Factors and Morbidity Outcomes

Congenital heart disease (CHD) co-occurring with fetal growth restriction (FGR) is clinically important but incompletely characterized. We assessed the proportion and subtype spectrum of CHD in term-born children with FGR, and factors associated with its presence and complexity.

Retrospective analysis of 375 term singleton children with documented FGR at a tertiary pediatric center. CHD required echocardiographic confirmation; isolated patent foramen ovale was excluded. Patients with multiple lesions were hierarchically classified as simple or complex. Multivariable logistic regression was restricted to characteristics available at or before birth.

CHD was confirmed in 96/375 children (25.6%): 71 (74.0%) simple, 25 (26.0%) complex. Atrial septal defect and patent ductus arteriosus were most frequent (each 45.8%), followed by patent foramen ovale (44.8%) and ventricular septal defect (32.3%). Severe FGR (aOR 2.012, 95% CI 1.222-3.313; p = 0.006) and genetic syndrome (aOR 5.969, 95% CI 2.565-13.889; p < 0.001) were independently associated with CHD presence. Within the CHD subgroup, genetic syndrome was also associated with complex disease (aOR 5.156, 95% CI 1.651-16.104; p = 0.005). Diagnosis occurred before six months in 95.8%. Hospitalization outcomes and comorbidity burden did not differ by complexity.

FGR severity and genetic syndrome were both independently associated with the presence of a cardiac defect, and genetic syndrome was further associated with its complexity. These findings support targeted rather than universal echocardiographic assessment. Directionality cannot be established from postnatal data.